Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Pediatric Case Report of Acute Torticollis Secondary to Atraumatic Cerebellar Hemorrhage.

Clinical practice and cases in emergency medicine·2026

Same author

Atypical High-Burden Breakthrough Varicella: A Diagnostic Pitfall in the Two-Dose Vaccine Era.

Cureus·2026

Same author

Response to: Letter to the Editor Re: Prehospital Trauma Compendium: Prehospital Management of Spinal Cord Injuries - A NAEMSP Comprehensive Review and Analysis of the Literature by Millin et al.

Prehospital emergency care·2025

Same author

Comparing Pediatric 72-Hour Emergency Department Returns: General vs Pediatric Emergency Departments.

The western journal of emergency medicine·2025

Same author

Approaches to Pediatric Traumatic Brain Injury: Diagnosis and Management.

Emergency medicine clinics of North America·2025

Same author

Prehospital Trauma Compendium: Prehospital Management of Spinal Cord Injuries - A NAEMSP Comprehensive Review and Analysis of the Literature.

Prehospital emergency care·2025

Search research articles

Related Experiment Video

Updated: Apr 2, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Persistent Pneumonia: Time to Take a Closer Look.

Timothy Ruttan¹, Robert Vezzetti, Jordan Scalo

¹From the *Pediatric Emergency Medicine, The University of Texas at Austin Dell Medical School; and †Austin Children's Chest Associates, Dell Children's Medical Center of Central Texas, Austin, TX.

Pediatric Emergency Care

|September 29, 2015

Summary

Pediatric bronchial tumors, though rare, require prompt diagnosis. This case highlights a bronchial mucoepidermoid carcinoma initially presenting as persistent pneumonia, emphasizing the need for thorough investigation in non-resolving pediatric respiratory cases.

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Experiment Videos

Last Updated: Apr 2, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Area of Science:

Pediatric Oncology
Pulmonology
Medical Imaging

Background:

Primary pulmonary tumors are uncommon in children, with carcinoid tumors and mucoepidermoid carcinomas being the most frequent types.
Early diagnosis and treatment are crucial for favorable outcomes in pediatric respiratory conditions.

Observation:

A pediatric patient presented with recurrent, unresolved wheezing and pneumonia, initially treated as a persistent infiltrate/atelectasis on chest films.
Advanced imaging, including computed tomography (CT) scans and bronchoscopy, were essential in identifying the underlying cause.

Findings:

A bronchial mucoepidermoid carcinoma was diagnosed in the pediatric patient after a comprehensive diagnostic workup.
The patient successfully underwent photoablation for the bronchial tumor, requiring a multidisciplinary team approach.

Implications:

Emergency physicians should consider rare diagnoses like pediatric bronchial tumors in cases of persistent, unresponsive pneumonia or wheezing.
Multidisciplinary collaboration among pediatric pulmonologists, surgeons, otolaryngologists, and oncologists is vital for managing pediatric bronchial tumors.
This case underscores the importance of advanced diagnostic tools in pediatric respiratory medicine when initial treatments fail.